The Uttar Pradesh (UP) and Tamil Nadu state governments are actively considering using the low dead space (LDS) syringes to ensure the optimum usage of available Covid-19 vaccines.
These syringes are imported from South Korea and enable in lessening the quantity of drug that is left in the dead space of the syringe after injection.
Moreover, it comes of great use in cutting down the wastage of vaccines, allowing around 20 per cent additional people to get their jabs.
Samsung is importing about one million LDS syringes as the company is undertaking an assistance program for the Covid-19 vaccination drive in India.
Major cities such as Lucknow and Noida are already using these syringes in UP, whereas the Greater Chennai Corporation will soon supply 3.5 lakh units of the same very soon.
Microbiologist Society of India President AM Deshmukh told The Times of India, “There is a dire need of 2,700 million doses per year in India, and if these syringes are used, we can get over 500 million more doses with the same amount of vaccine.”
States such as Jharkhand, Chhattisgarh and Tamil Nadu have recorded a massive 37.3 per cent, 30.2 per cent and 15.5 per cent Covid-19 vaccine wastage, respectively; something, which has probably necessitated a widespread use of the LDS syringes to administer the doses.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.